Corcept Therapeutics Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 16.05 M | $742.81 M | 100.00% | 15.53% |
| VANGUARD GROUP INC | 11/13/2024 | 10.01 M | $463.09 M | 4.74% | 9.68% |
| INGALLS & SNYDER LLC | 11/14/2024 | 8.27 M | $382.59 M | 0.35% | 8.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 6.51 M | $301.24 M | -5.84% | 6.30% |
| PARALLEL ADVISORS, LLC | 11/13/2024 | 3.81 M | $176.50 M | -0.05% | 3.69% |
| STATE STREET CORP | 11/14/2024 | 3.52 M | $162.87 M | 0.57% | 3.40% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.53 M | $117.19 M | -5.37% | 2.45% |
| NOVO HOLDINGS A/S | 10/24/2024 | 2.41 M | $111.60 M | 0.00% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.38 M | $110.11 M | 4.36% | 2.30% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 1.58 M | $73.15 M | 6.55% | 1.53% |
| BOSTON TRUST WALDEN CORP | 10/24/2024 | 1.51 M | $70.07 M | -4.41% | 1.46% |
| MORGAN STANLEY | 11/14/2024 | 1.46 M | $67.50 M | 10.86% | 1.41% |
| FMR LLC | 11/13/2024 | 1.36 M | $63.12 M | 24.58% | 1.32% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 1.32 M | $61.00 M | -13.37% | 1.28% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.22 M | $56.64 M | 40.53% | 1.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.03 M | $47.51 M | 5.47% | 0.99% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 859,563 | $39.78 M | 20.04% | 0.83% |
| INVESCO LTD. | 11/12/2024 | 857,358 | $39.68 M | 28.86% | 0.83% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 788,064 | $36.47 M | -16.97% | 0.76% |
| ABRDN PLC | 10/25/2024 | 666,952 | $30.87 M | 27.13% | 0.65% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 622,171 | $28.79 M | -19.14% | 0.60% |
| CERITY PARTNERS LLC | 11/12/2024 | 611,784 | $28.31 M | -9.44% | 0.59% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 605,408 | $28.02 M | -10.73% | 0.59% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 533,693 | $24.70 M | -6.50% | 0.52% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 495,658 | $22.94 M | -4.02% | 0.48% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 473,021 | $21.89 M | -1.16% | 0.46% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 457,100 | $21.15 M | -11.24% | 0.44% |
| BURNEY CO/ | 10/18/2024 | 434,164 | $20.09 M | 4.17% | 0.42% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 414,500 | $19.18 M | 38.54% | 0.40% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 392,273 | $18.15 M | 11.09% | 0.38% |
| ROYCE & ASSOCIATES LP | 11/06/2024 | 363,272 | $16.81 M | 3.71% | 0.35% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 356,050 | $16.48 M | -9.58% | 0.34% |
| MAN GROUP PLC | 11/14/2024 | 350,533 | $16.22 M | -57.76% | 0.34% |
| BARCLAYS PLC | 11/19/2024 | 325,953 | $15.08 M | 23.26% | 0.32% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 324,017 | $15.00 M | -5.21% | 0.31% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 315,955 | $14.62 M | 32.17% | 0.31% |
| FAS WEALTH PARTNERS, INC. | 10/17/2024 | 315,749 | $14.61 M | -0.01% | 0.31% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 278,146 | $12.87 M | 2.29% | 0.27% |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 11/06/2024 | 258,753 | $11.98 M | -1.73% | 0.25% |
| JUPITER ASSET MANAGEMENT LTD | 11/12/2024 | 256,270 | $11.86 M | -52.60% | 0.25% |
| JPMORGAN CHASE & CO | 11/08/2024 | 253,070 | $11.71 M | 43.38% | 0.24% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/18/2024 | 251,068 | $11.62 M | 97.15% | 0.24% |
| M&G PLC | 10/31/2024 | 242,901 | $11.17 M | 100.00% | 0.24% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 242,791 | $11.00 M | 1.03% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 239,226 | $11.07 M | -20.87% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 222,080 | $10.28 M | -0.58% | 0.21% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 211,563 | $9.79 M | 7.18% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 205,800 | $9.52 M | -51.46% | 0.20% |
| RHUMBLINE ADVISERS | 11/12/2024 | 202,832 | $9.39 M | 0.02% | 0.20% |
| BARCLAYS PLC | 11/19/2024 | 200,000 | $9.26 M | 100.00% | 0.19% |
Corcept Therapeutics Incorporatedinstitutional Ownership - FAQ's
During the previous two years, 411 institutional investors and hedge funds held shares of Corcept Therapeutics Incorporated. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 16.05 M
VANGUARD GROUP INC: 10.01 M
INGALLS & SNYDER LLC: 8.27 M
RENAISSANCE TECHNOLOGIES LLC: 6.51 M
Parallel Advisors, LLC: 3.81 M
STATE STREET CORP: 3.52 M
84.30% of Corcept Therapeutics Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 113.50 M shares in the last 24 months. This purchase volume represents approximately $5.84 B in transactions.